SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-329000
Filing Date
2021-11-15
Accepted
2021-11-15 08:10:59
Documents
14
Period of Report
2021-11-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d243248d8k.htm   iXBRL 8-K 24437
2 EX-99.1 d243248dex991.htm EX-99.1 73767
6 GRAPHIC g243248page0001.jpg GRAPHIC 4053
  Complete submission text file 0001193125-21-329000.txt   240550

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA urgn-20211111.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20211111_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20211111_pre.xml EX-101.PRE 11404
7 EXTRACTED XBRL INSTANCE DOCUMENT d243248d8k_htm.xml XML 3366
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 211406503
SIC: 2834 Pharmaceutical Preparations